Shi, Xin, et al. “Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin”. Gastroenterology Research, vol. 19, no. 5, Jan. 2026, pp. 295-01, https://doi.org/10.14740/gr2193.